Skip to main content
. Author manuscript; available in PMC: 2022 Apr 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2021 Jul 16;30(10):1826–1833. doi: 10.1158/1055-9965.EPI-21-0234

Table 5.

Age-adjusted relative risk (RR) and 95% confidence interval (CI) for DES dose and prostate cancer (Mayo cohort only)

Cases Person-years RR (95%CI)
Unexposed 30 18,080 1.0
Low dose (lowest 25th percentile) 15 4,349 1.42 (0.76, 2.66)
Medium dose (25th – 75th percentile) 11 7,951 0.84 (0.42, 1.68)
High dose (highest 25% percentile) 6 3,893 0.80 (0.33, 1.93)
Missing dose 9 3,893 1.35 (0.64, 2.85)